Spyre Therapeutics Shares up 6.1% After Evercore ISI Initiates Coverage With Outperform Rating
Evercore ISI對Spyre Therapeutics進行覆蓋,並給予跑贏大盤的評級,股價上漲了6.1%。
Spyre Therapeutics Shares up 6.1% After Evercore ISI Initiates Coverage With Outperform Rating
Evercore ISI對Spyre Therapeutics進行覆蓋,並給予跑贏大盤的評級,股價上漲了6.1%。
譯文內容由第三人軟體翻譯。